GLP-1 weight-loss drugs alter brain circuits in the amygdala and dopamine system to reduce the motivation to seek out high-calorie foods.

Common GLP-1s include semaglutides like Ozempic and Wegovy, and tirzepatides like Zepbound and Mounjaro. These drugs work by mimicking a natural hormone to regulate appetite, blood sugar, and feelings ...

A new study suggests that newer oral weight loss drugs may do more than suppress appetite, potentially altering brain ...

GLP-1 medications are marketed under brands including Wegovy. Credit: Shelby Knowles/Bloomberg via Getty Images More than eight in ten of users of GLP-1 drugs in the US experienced “major changes” in ...

The rise of GLP-1 weight loss drugs is altering shopping habits, reducing demand for high-calorie foods while boosting sales of fresh produce and smaller clothing sizes. Retailers are adapting by ...

New research reveals that young adults with higher body shame and weight concerns are more likely to consider GLP-1 medications, despite significant side effects, unless buffered by strong body ...

For restaurants and food companies, the increasing adoption of GLP-1 drugs present both an opportunity and a threat to their businesses. About one in every eight U.S. adults is currently taking a ...

More than eight in ten of users of GLP-1 drugs in the US experienced “major changes” in their food and beverage preferences after starting the medication, a new study has claimed. The research, ...